Article Details
Retrieved on: 2024-04-10 15:02:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This portion of the study evaluated the combination of mRNA-4157 and Merck's blockbuster immuno-oncology drug Keytruda in patients with human ...
Article found on: www.zacks.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here